Astarta (AST) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Nov, 2025Executive summary
Consolidated revenues for 1Q25 declined 25% year-over-year to EUR125m, mainly due to lower sales volumes in agriculture and sugar segments.
Gross profit fell 38% year-over-year to EUR33m, with gross margin narrowing to 27% from 32% on higher cost of sales.
EBITDA decreased 7% year-over-year to EUR27m, but EBITDA margin improved to 21% from 17% due to lower selling and distribution expenses.
Net profit for 1Q25 was EUR6.4m, down from EUR9.0m in 1Q24, with a net profit margin of 5%.
Export sales contributed 59% of total revenue, down from 69% in 1Q24.
Financial highlights
Operating cash flow dropped 51% year-over-year to EUR34m, mainly due to destocking and lower trade receivables.
Investing cash flow rose 3.3x year-over-year to EUR21m, focused on machinery replacement and new production facility construction.
Net financial debt (excluding lease liabilities) was a positive cash position of EUR17m at 1Q25, up from EUR11m in 1Q24.
Adjusted net debt/EBITDA ratio improved to 0.1x from -0.02x in 1Q24, indicating strong liquidity.
Export sales contributed 59% of consolidated revenue in 1Q25, down from 69% in 1Q24.
Outlook and guidance
Sowing campaign for 2025 completed, though delayed by adverse weather; crop care and early grain harvest preparations ongoing.
Management expects to meet loan covenants for the next 12 months, with stable external long-term debt and continued export opportunities.
Ongoing military conflict in Ukraine remains a significant uncertainty, but assets and operations are currently unaffected.
Ukrainian grain and oilseed exports expected to remain pressured by lower harvest and carryover stocks; domestic prices stable but driven by internal factors.
Soybean acreage in Ukraine forecast to decrease by 9% year-over-year in 2025.
Latest events from Astarta
- Revenue up 12% y-o-y to EUR321m, but profit and margins fell amid market and regulatory risks.AST
Q2 202422 Jan 2026 - Revenue up 13%, net profit up 35%, and export share at 64% amid strong cash flow.AST
Q3 202412 Jan 2026 - Net profit and margins rose, supporting major investments despite ongoing risks.AST
Q4 202424 Dec 2025 - Revenue fell 29% year-over-year, but EBITDA margin rose to 36% amid major investments and market risks.AST
Q2 202523 Nov 2025 - Revenue and profit fell sharply, margins compressed, and net debt surged amid war and weak crops.AST
Q3 202521 Nov 2025